al-01567 has been researched along with valproate sodium in 1 studies
Studies (al-01567) | Trials (al-01567) | Recent Studies (post-2010) (al-01567) | Studies (valproate sodium) | Trials (valproate sodium) | Recent Studies (post-2010) (valproate sodium) |
---|---|---|---|---|---|
13 | 0 | 2 | 82 | 1 | 42 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyer, TA; Mylari, BL; Siegel, TW | 1 |
1 other study(ies) available for al-01567 and valproate sodium
Article | Year |
---|---|
A highly specific aldose reductase inhibitor, ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate, and its congeners.
Topics: Alcohol Dehydrogenase; Aldehyde Reductase; Animals; Chemical Phenomena; Chemistry; Diabetes Mellitus, Experimental; Female; Humans; Kidney; Lens, Crystalline; Molecular Structure; Placenta; Pyrrolidonecarboxylic Acid; Sciatic Nerve; Sorbitol; Structure-Activity Relationship; Swine | 1991 |